Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma-Reference-Cited by-同舟云学术

Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma

Published:2017-12-13 Issue:4 Volume:20 Page:472-483
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Mahlokozera Tatenda¹,Vellimana Ananth K¹,Li Tiandao²,Mao Diane D¹,Zohny Zohny S¹,Kim David H¹,Tran David D³,Marcus Daniel S⁴,Fouke Sarah J⁵,Campian Jian L⁶,Dunn Gavin P¹⁶⁷⁸,Miller Christopher A²,Kim Albert H¹⁶⁹¹⁰

Affiliation:

1. Department of Neurological Surgery, Washington University School of Medicine, St Louis, Missouri

2. McDonnell Genome Institute, Washington University School of Medicine, St Louis, Missouri

3. Lillian S. Wells Department of Neurosurgery, University of Florida College of Medicine, Gainesville, Florida

4. Department of Radiology, Washington University School of Medicine, St Louis, Missouri

5. Department of Neurosurgery, St Luke’s Hospital, St Louis, Missouri

6. Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri

7. Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, Missouri

8. Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri

9. Department of Neurology, Washington University School of Medicine, St Louis, Missouri

10. Department of Developmental Biology, Washington University School of Medicine, St Louis, Missouri

Funder

Christopher Davidson and Knight Family

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/4/472/24688133/nox232.pdf

Reference49 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

2. Molecular and cellular heterogeneity: the hallmark of glioblastoma;Aum;Neurosurg Focus,2014

3. Comprehensive genomic characterization defines human glioblastoma genes and core pathways;Cancer Genome Atlas Research Network;Nature,2008

4. An integrated genomic analysis of human glioblastoma multiforme;Parsons;Science,2008

5. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis;Phillips;Cancer Cell,2006

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?;Current Treatment Options in Oncology;2024-04-23

2. Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma;Clinical Cancer Research;2024-04-19

3. Insight into spatial intratumoral genomic evolution in glioblastoma;2024-04-04

4. Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression;Neuro-Oncology;2023-12-23

5. Insight into spatial intratumoral genomic evolution in glioblastoma;2023-09-12